Morphine-sparing effect of diclofenac in cancer pain
- 1 January 1993
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 44 (1) , 1-5
- https://doi.org/10.1007/bf00315271
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cancer pain classification: a controversial issuePAIN®, 1991
- Central analgesic effect of acetaminophen but not of aspirinClinical Pharmacology & Therapeutics, 1991
- Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer painPain, 1989
- The combination of ibuprofen and oxycodone/acetaminophen in the management of chronic cancer painClinical Pharmacology & Therapeutics, 1988
- The Treatment of Cancer PainNew England Journal of Medicine, 1985
- Combination Therapy with Ibuprofen and Methadone for Chronic Cancer PainThe American Journal of Medicine, 1984
- The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: Possible central analgesic action of acidic nonsteroidal antiinflammatory drugs.The Japanese Journal of Pharmacology, 1984
- Use of non‐steroidal anti‐inflammatory drugs in the treatment of pain in cancer.British Journal of Clinical Pharmacology, 1980
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979
- Central and peripheral antialgesic action of aspirin-like drugsEuropean Journal of Pharmacology, 1978